Related Experiment Video
Updated: Dec 27, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Ending tuberculosis by 2030-Pipe dream or reality?
Jeremiah M Chakaya1, Anthony D Harries2, Guy B Marks3
1International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Medicine, Therapeutics, Dermatology and Psychiatry, Kenyatta University, Nairobi, Kenya.
Tuberculosis (TB) is a major global health issue. Ending TB requires active case finding, addressing social factors, and improving health services, alongside new tools.
Area of Science:
- Public Health
- Infectious Diseases
- Global Health
Background:
- Tuberculosis (TB) remains a significant global health challenge, with 10 million illnesses and 1.5 million deaths in 2018.
- The End TB Strategy aims to reduce TB incidence and mortality by 90% and 95% by 2035, respectively.
Purpose of the Study:
- To assess progress towards the End TB Strategy targets.
- To identify challenges hindering TB reduction efforts.
- To highlight the importance of new tools and strategies for TB elimination.
Main Methods:
- Review of progress data related to TB incidence and mortality.
- Analysis of factors influencing TB control and elimination efforts.
- Discussion of the role of new diagnostic and therapeutic tools.
Main Results:
- Progress towards End TB targets is ongoing but faces significant challenges.
- Active case finding, multi-sectoral approaches, and improved health services are crucial.
- Development and deployment of innovative tools are essential for accelerating progress.
Conclusions:
- Achieving the End TB Strategy goals is feasible with sustained and intensified efforts.
- A comprehensive approach addressing social determinants and enhancing healthcare is vital.
- Continued innovation and global collaboration are key to ending TB as a public health threat.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

